GlassScriptPhysician profile
Morgan Nickerson
NPI 1477073724
$5,929.68
in general payments reported to CMS, 2019-2025
14 companies · $1,464 in 2025
The $1,464 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $357 · 2021: $1,615 · 2022: $219 · 2023: $1,758 · 2025: $1,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,486 · Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,486.24 |
| Food and Beverage | $735.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,117.54 | 2023-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,993.91 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,143.95 | 2019-2022 | |
| Stryker Corporation | $367.69 | 2021-2023 | Mako, Triathlon |
| Pacira Therapeutics, INC. | $106.16 | 2019 | |
| Novus Surgical Consultants | $49.92 | 2023 | |
| Depuy Synthes Sales INC. | $25.34 | 2022 | |
| Ethicon US, LLC | $24.49 | 2022 | |
| Molnlycke Health Care US, LLC | $21.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $19.26 | 2021 | |
| Amarin Pharma, INC. | $18.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.63 | 2020 | |
| Novo Nordisk INC | $13.16 | 2019 | |
| Bioventus LLC | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Nickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.